Partnering.

Skyline’s business strategy is to evolve a broad portfolio of genomics-based diagnostic tests and to commercialize these products on a global scale.

 

Therefore, it is key to Skyline to form partnerships with pharma and biotech companies, as well as with academic and non-academic organizations, and to collaborate on development of new IVDs.

 

  • Pharmaceutical companies

    Tailoring therapy based on genetic profiles of individual patients in order to maximize therapeutic response and to prevent adverse side-effects are essential to optimize modern health care. Skyline has all relevant expertise and know-how to discover genetic markers or signatures of clinical relevance and to develop these into practical and...

    Read more >>

  • Inventors of new biomarkers or signatures

    Skyline Diagnostics is a leading company in developing genetic biomarkers to reliable diagnostic assays of high clinical relevance.

    Read more >>

Rotterdam Science Tower, Marconistraat 16, 3029 AK Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: info@skyline-diagnostics.com